The study compared outcomes at a five-year follow-up, using data of 245 patients across 23 centers.
Here are six things to know:
1. TDR patients experienced a 61.9 percent composite overall success, compared to 52.2 percent for ACDF patients.
2. The two groups experienced similar improvements in Neck Disability Index, visual analog scales assessing neck and arm pain and Short Form-12 health survey scores.
3. Researchers didn’t discover major differences in adverse events or major complications between the two groups.
4. TDR patients maintained range of motion through the five-year follow-up.
5. TDR patients experienced significantly lower rates of device-related subsequent surgeries and adjacent segment degeneration at the superior level.
6. Researches concluded TDR with the Mobi-C serves as a safe and effective alternative to ACDF.
More articles on spine:
When the work day ends: What do spine surgeons to relax
5 key notes on spine surgery patient-reported outcomes instruments
Neurosurgeon Dr. Jeffrey Masciopinto joins Wellbe’s new advisory board: 5 notes
